Navigation Links
Plaintiffs Obtain $240 Million Amended Settlement In Guidant Defibrillators Products Liability Litigation
Date:11/19/2007

- $45 Million More Than Original Agreement -

- Relief for Up To 8,550 Patient Plaintiffs -

MINNEAPOLIS, Nov. 19 /PRNewswire/ -- Co-Lead Counsel for the Plaintiffs' Steering Committee in the Guidant Medical Device Litigation announced today that an amended settlement agreement has been obtained on behalf of 8,550 patient plaintiffs who asserted claims against Guidant Corporation, Boston Scientific Corporation and other entities (hereinafter collectively, "Defendants"). The plaintiffs had claimed that Defendants knowingly sold them inherently defective defibrillator devices with potential life-threatening defects over a period of three years.

The amended settlement expands a prior agreement obtained in July 2007, which had provided for a recovery of $195 million to settle over 5,600 claims. After additional injured patients stepped forward, the agreement was amended to provide up to $240 million in compensation. The successful settlement mediation sessions were conducted before U.S. Magistrate Judge Arthur J. Boylan in Minneapolis over a 15-month period.

Charles S. Zimmerman, co-lead attorney for the Plaintiffs' Steering Committee, stated, "This amended agreement is great news for the patient plaintiffs and will provide them and their families with substantial relief. Beyond this, the settlement serves the public good by highlighting that transparency and full and proper disclosure are paramount to the public and to those regulatory bodies entrusted to protect the public's interests, particularly in the areas of public health and safety. It also highlights the need for continued and stronger regulatory oversight of companies that are in the business of manufacturing and selling life-saving devices to consumers. We believe that with these results, the settlement truly benefits all parties."

Press Contact:

Peter Hill

Kekst and Company

212-521-4800

peter-hill@kekst.com


'/>"/>
SOURCE The Guidant's Plaintiffs' Steering Committee
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. United Animal Nations Offers Financial Assistance Grants of up to $500 to Help Southern California Fire Victims Obtain Vet Care, Temporary Boarding for Pets
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
4. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
5. 1.5 million children could be saved
6. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
7. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
8. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
9. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
10. £5 million investment in personalized medicines to cut patient deaths
11. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 2017 , ... Youth Futures International (YFI) premiered its Serve, Learn, & Empower ... college students who have participated in the program every summer. The 2017 Serve, ... applications for enrollment. Visit http://www.ghana.yfiexperience.org to learn more. , “I have ...
(Date:3/29/2017)... Rouge, Louisiana (PRWEB) , ... March 29, 2017 ... ... HeartBoost in three Hours at a Walgreens store in Mississippi. AngioGenesis Labs, makers ... at Walgreens Stores in two southeastern states. Ingredients in HeartBoost, an over the ...
(Date:3/29/2017)... Mt. Horeb, WI (PRWEB) , ... March 29, 2017 , ... ... her patients on early orthodontic treatment and accepting new pediatric patients, with or without ... can help young patients have a better orthodontic outcome and experience. When patients receive ...
(Date:3/29/2017)... ... March 29, 2017 , ... Curio Wellness , a ... the finalization of the company’s executive management team with prominent executives from both inside ... Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who has more than twenty ...
(Date:3/29/2017)... Ca (PRWEB) , ... March 29, 2017 , ... Immunotherapy ... a growing number of cancers and is touted to be the next revolution in ... thus far, has been in the form of immune checkpoint inhibitors such as PD-1 ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... March 29, 2017  The leader in accelerated orthodontics, ... Sam Daher , Manal Ibrahim , ... Couchat will be the featured microlecture presenters at the ... Association of Orthodontists (AAO) Annual Session, April 21-25, 2017. ... microlectures beginning daily at 11:20 a.m. On the opening ...
(Date:3/29/2017)... , March 29, 2017  Glenmark Pharmaceuticals, a ... GSP 301, an investigational fixed-dose combination of mometasone ... administered twice-daily as a nasal spray being studied ... results are from a recently completed Phase 3 ... 301 combination therapy versus mometasone, olopatadine or placebo. ...
(Date:3/29/2017)... , March 29, 2017 ... a report, which provides an exhaustive study of ... study, nearly 242 companies are functional in this ... competitive. With the leading companies, such as GlaxoSmithKline ... LP, focusing aggressively on various marketing strategies to ...
Breaking Medicine Technology: